Clinical Trials Directory

Trials / Sponsors / Translational Oncology Research International

Translational Oncology Research International

Academic / Other · 11 registered clinical trials.

StatusTrialPhaseStarted
CompletedDasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreati
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer
Phase 22011-01-13
CompletedEverolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomac
Esophageal Cancer, Gastric Cancer
Phase 22009-09-01
CompletedDocetaxel, Carboplatin, and Trastuzumab and/or Lapatinib in Treating Women With Stage I, Stage II, or Stage II
Breast Cancer
Phase 22009-04-01
CompletedStudy of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric Cardia
Unresectable Adenocarcinoma of the Esophagus, Metastatic Adenocarcinoma of the Esophagus, Unresectable Adenocarcinoma of Gastric Cardia
Phase 22007-12-01
CompletedBevacizumab Plus Capecitabine (Xeloda) in Patients With Untreated Metastatic Colorectal Cancer
Colorectal Cancer
Phase 22006-03-01
CompletedTreatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
Prostate Cancer
Phase 22006-01-01
CompletedDocetaxel With Bevacizumab as First-Line Therapy in Treating Women With Stage IV Breast Cancer
Breast Cancer
Phase 22005-05-01
CompletedNeoadjuvant TAC Plus or Minus Bevacizumab(AVF3299)
Breast Cancer
Phase 22005-05-01
TerminatedFulvestrant and/or Trastuzumab as First-Line Therapy in Treating Postmenopausal Women With Stage IV Breast Can
Breast Cancer
Phase 22005-04-01
CompletedErlotinib With or Without Fulvestrant in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Can
Lung Cancer
Phase 22004-10-28
CompletedTreatment of HER2-Positive Metastatic Breast Cancer With Herceptin and Bevacizumab (Antibodies Against HER2 an
Breast Cancer
Phase 1 / Phase 22003-06-01